| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $667.2M | +15.1% |
| R&D Expense | $74.6M | -17.6% |
| SG&A Expense | $377.2M | +23.8% |
| Operating Income | $46.1M | -46.4% |
| Interest Expense | $4.7M | -76.4% |
| Pre-tax Income | $60.7M | -17.0% |
| Income Tax | $32K | -99.8% |
| Net Income | $60.7M | +13.6% |
| EPS (Basic) | $1.13 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.1M | -54.2% |
| Short-term Investments | $368.2M | +170.3% |
| Accounts Receivable | $165.5M | +11.1% |
| Inventory | $91.5M | +6.5% |
| Current Assets | $734.2M | +22.0% |
| Total Assets | $1.70B | +0.8% |
| Current Liabilities | $688.0M | +118.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $116.8M | -8.1% |
| Investing Cash Flow | -$216.7M | -164.5% |
| Financing Cash Flow | -$10.5M | +92.0% |
| +11.9% |
| EPS (Diluted) | $1.04 | +6.1% |
| Total Liabilities |
| $816.3M |
| -6.5% |
| Stockholders' Equity | $886.2M | +8.6% |